Share this story
Reporting
Reporting
China has authorized the first human trials for brain-computer interface (BCI) devices, marking a significant step in the nation's push to develop its own neurotechnology sector. The implants, developed by the Chinese Academy of Sciences, aim to translate neural signals into commands for external devices. This development positions China as a potential competitor to established players like Elon Musk's Neuralink, which has also been advancing its BCI technology for medical and potentially broader applications.
The approval signifies China's strategic interest in the burgeoning field of neurotechnology, which holds promise for treating neurological disorders, restoring lost motor function, and enhancing human capabilities. By investing in and now greenlighting human trials, China signals its intent to become a leader in this advanced technological arena, potentially influencing the global landscape of brain-computer interfaces and their future development.
“China approves brain chip devices to rival Elon Musk’s Neuralink”
Yahoo Finance UK
The Musk Wire aggregates and deduplicates public feeds; it does not republish articles. Continue to news.google.com to read the reporting in full.